News Home

Do Traders Think Walgreens Boots Alliance Inc (WBA) Can Turn Around Wednesday?

Wednesday, February 28, 2024 03:30 PM | InvestorsObserver Analysts

Mentioned in this article

Do Traders Think Walgreens Boots Alliance Inc (WBA) Can Turn Around Wednesday?

Walgreens Boots Alliance Inc (WBA) stock has fallen 2.80% over the past week and gets a Neutral rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,neutral
Walgreens Boots Alliance Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on WBA!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With WBA Stock Today?

Walgreens Boots Alliance Inc (WBA) stock is trading at $21.14 as of 3:22 PM on Wednesday, Feb 28, a drop of -$0.49, or -2.29% from the previous closing price of $21.63. The stock has traded between $21.11 and $21.68 so far today. Volume today is below average. So far 6,111,838 shares have traded compared to average volume of 13,683,426 shares.

More About Walgreens Boots Alliance Inc

Walgreens Boots Alliance is a leading retail pharmacy chain with about 13,000 stores in the U.S. and internationally. Walgreens' core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading share of the domestic prescription drug market at about 20%. In 2021, the company sold a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstore (40%). Click Here to get the full Stock Report for Walgreens Boots Alliance Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App